Billionaire Philippe Laffont shifts focus from Nvidia to Novo Nordisk and Eli Lilly
From Nasdaq: 2024-12-29 05:39:00
The Securities and Exchange Commission provides easy access to the trading details of top investors through Form 13F filings. Philippe Laffont of Coatue Management, managing $26.9 billion, is known for investing in tech and healthcare stocks. Coatue’s stake in Nvidia was worth $1.2 billion in June, but has since been reduced by 26%. The fund has shifted its focus to Novo Nordisk and Eli Lilly, increasing stakes significantly in both drugmakers.
Novo Nordisk and Eli Lilly are leading the market for anti-obesity drugs with semaglutide and tirzepatide, respectively. The market for these drugs could grow from $6 billion in 2023 to $105 billion in 2030. Novo Nordisk’s semaglutide sales reached $19.8 billion in the first nine months of 2024, with promising results for next-generation treatment CagriSema. Eli Lilly’s tirzepatide sales exceeded $11 billion during the same period, showing potential to surpass Novo Nordisk in the GLP-1 drug market.
Investors are advised to closely monitor the competition between Novo Nordisk and Eli Lilly in the GLP-1 drug market. While Novo Nordisk’s CagriSema shows promise, Eli Lilly’s retatrutide could potentially outperform. The market is already pricing in high expectations for both companies, with Novo Nordisk trading at 27.9 times forward-looking earnings and Eli Lilly at about 60 times. Patient investors may see market-beating gains as demand for GLP-1 drugs continues to rise.
For those seeking a second chance at lucrative opportunities, experts are issuing “Double Down” stock recommendations for companies with high growth potential. Past recommendations for Nvidia, Apple, and Netflix have yielded significant returns. The current recommendations offer a unique opportunity to invest before potential market surges. Investors are encouraged to act now to capitalize on these promising stocks.
Read more at Nasdaq: Billionaire Philippe Laffont Is Selling Artificial Intelligence Champion Nvidia and Piling Into These Two Industry Leaders